Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium

Por Seferina, Shanly C., de Boer, Maaike, Derksen, M. Wouter, van den Berkmortel, Franchette, van Kampen, Roel J.W., van de Wouw, Agnès J., Joore, Manuela, Peer, Petronella G.M., Voogd, Adri C., Tjan-Heijnen, Vivianne C.G.
Publicado no Oncologist (2016)

Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium

Por Seferina, Shanly C., Ramaekers, Bram L.T., de Boer, Maaike, Dercksen, M. Wouter, van den Berkmortel, Franchette, van Kampen, Roel J.W., van de Wouw, Agnès J., Voogd, Adri C., Tjan Heijnen, Vivianne C.G., Joore, Manuela A.
Publicado no Oncotarget (2017)

The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches

Por Lobbezoo, Dorien, Truin, Wilfred, Voogd, Adri, Roumen, Rudi, Vreugdenhil, Gerard, Dercksen, Marcus Wouter, van den Berkmortel, Franchette, Smilde, Tineke, van de Wouw, Agnes, van Kampen, Roel, van Riel, Johanna, Peters, Natascha, Peer, Petronella, Tjan-Heijnen, Vivianne C.G.
Publicado no Oncotarget (2016)

Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium

Por Seferina, Shanly C., Lobbezoo, Dorien J.A., de Boer, Maaike, Dercksen, M. Wouter, van den Berkmortel, Franchette, van Kampen, Roel J.W., van de Wouw, Agnès J., de Vries, Bart, Joore, Manuela A., Peer, Petronella G.M., Voogd, Adri C., Tjan-Heijnen, Vivianne C.G.
Publicado no Oncologist (2015)